Ignite Creation Date:
2025-12-24 @ 11:47 PM
Ignite Modification Date:
2026-01-10 @ 6:49 PM
Study NCT ID:
NCT03359551
Status:
COMPLETED
Last Update Posted:
2023-02-10
First Post:
2017-11-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Natural History of the Progression of Choroideremia Study
Sponsor:
NightstaRx Ltd, a Biogen Company
Organization:
Study Overview
Official Title:
Natural History of the Progression of Choroideremia Study
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NIGHT
Brief Summary:
The objective of this natural history study is to gain a better understanding of the progression of choroideremia (CHM) and add to the knowledge base for this rare disease.
Detailed Description:
This study was previously posted by NightstaRx Ltd. In October 2020, sponsorship of the trial was transferred to Biogen.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| NSR-CHM-OS1 | OTHER | NightstaRx Ltd, a Biogen Company | View |